SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001193125-19-305731
Filing Date
2019-12-04
Accepted
2019-12-04 07:30:59
Documents
6
Period of Report
2019-12-02
Items
Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K d833832d8k.htm 8-K 28388
2 EX-10.1 d833832dex101.htm EX-10.1 8774
3 EX-10.2 d833832dex102.htm EX-10.2 32048
4 EX-99.1 d833832dex991.htm EX-99.1 10602
5 GRAPHIC g833832g1203233433456.jpg GRAPHIC 3285
6 GRAPHIC g833832g1203234453319.jpg GRAPHIC 3421
  Complete submission text file 0001193125-19-305731.txt   90607
Mailing Address 22 BOSTON WHARF RD 9TH FLOOR BOSTON MA 02210
Business Address 22 BOSTON WHARF RD 9TH FLOOR BOSTON MA 02210 617-207-0202
AKCEA THERAPEUTICS, INC. (Filer) CIK: 0001662524 (see all company filings)

IRS No.: 472608175 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-38137 | Film No.: 191267345
SIC: 2834 Pharmaceutical Preparations